Diagnostic Code 6730 · 38 CFR §4.97
Tuberculous pleurisy is inflammation of the pleural membranes caused by tuberculosis infection. It can occur in active or inactive phases and may leave permanent pleural thickening that restricts lung function. Veterans exposed to TB during service in endemic areas may develop this condition. The VA rates active cases at 100% with a mandatory total rating period, then rates residuals based on pleural damage and PFT results.
| Rating | Criteria |
|---|---|
| 100% | Active tuberculous pleurisy with ongoing infection. Total rating applies during active phase and for a period after stabilization. |
| 50% | Significant residual pleural thickening or effusion with moderate to severe restrictive impairment on PFTs. |
| 30% | Moderate residual pleural disease with mild to moderate PFT impairment. |
| 0% | Fully resolved with no residual pleural thickening or PFT impairment. |
Sputum cultures or other microbiological evidence of TB (active cases). Chest imaging showing TB-related changes (cavities, fibrosis, calcifications). PFTs documenting residual impairment. Treatment records showing completed anti-TB regimen. Documentation of service in TB-endemic areas or close-contact exposure.
TB has a unique graduated rating schedule. Active TB receives a mandatory 100% rating that continues for a specified period after the disease is determined inactive. The rating then steps down gradually based on residual damage. This graduated approach is different from other respiratory conditions that are rated solely on current PFT results.
While uncommon, TB exposure can occur during deployments to regions with high prevalence (parts of Africa, Asia, Eastern Europe) or in confined military settings. Some veterans are diagnosed with latent TB that reactivates years later. The VA recognizes these service connections.